期刊文献+

左旋卡尼汀治疗不稳定型心绞痛的疗效观察 被引量:1

Therapeutic effect of L-carnitine in treatment of patients with unstable angina pectoris
下载PDF
导出
摘要 目的观察左旋卡尼汀治疗不稳定型心绞痛的疗效。方法实验组在常规治疗基础上静脉滴注左旋卡尼汀2 g,1次/d,连用10 d;对照组单纯给予常规治疗。10 d后观察2组心绞痛和心电图的变化。结果实验组临床总有效率89%,心电图总有效率74%,对照组分别为63%和46%,2组有显著性差异,且治疗组未见不良反应。结论左旋卡尼汀联合常规药物治疗不稳定型心绞痛优于单纯常规治疗。 Objective It is to observe the therapeutic effect of L-earnitine in treatment of patients with unstable angina pectoris(UAP). Methods 70 eases of UAP patients randomly divided into 2 groups. On the basis of routine treatment, patients in the therapeutic group were given L-earnitine (2g/d) for 10 days, while patients in the control group were only given the routine therapy. 10 days later, the change of angina peetoris and ECG were observed. Results The effective rates of angi- na pectoris and ischemie ST - T changes on ECG of the therapeutic group were 89 % and 74 % respectively, compared with the control group(63 % and 46 % ), P 〈 0.05. No adverse reactions related to the drug were observed. Conclusion The therapy of L-earnitine in combination with the routine drugs is better than the single routine treatment in the treatment of the UAP.
作者 周纪星
出处 《现代中西医结合杂志》 CAS 2007年第9期1180-1181,共2页 Modern Journal of Integrated Traditional Chinese and Western Medicine
关键词 左旋卡尼汀 不稳定型心绞痛 治疗 L-earnitine unstable angina peetoris therapy
  • 相关文献

参考文献7

二级参考文献32

  • 1第一届全国内科学术会议心血管病组.关于冠状动脉性心脏病命名及诊断标准的建议[J].中华心血管病杂志,1981,9(1):75-76.
  • 2陈妙茹 邓斌.左旋肉碱治疗冠心病心绞痛疗效观察[J].实用医学杂志,2000,16(3):195-195.
  • 3Bremer J. Carnitine metabolism and function [J]. Physiol Res, 1983,63:1420-1428.
  • 4Regitz V, Shug AL, Fleck E. Defective myocardial metabolism in congestive heart failure secondary to dilated cardiomyopathy and to coronary hypertensive and valvular heart disease[J]. Am J Cardiol,1990,65: 755-803.
  • 5Yusuf S, Sleight P, Pogue J, et al. Effects of angiotensin-converting enzyme, ramipil, on cardiovascular events in high 0risk patients. The Heart Outcomes Prevention Evaluation Study Investigators[J]. N Engl J Med, 2000,342(3):145-153.
  • 6Pott B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure [J]. N Engl J Med, 1999,341;709-717.
  • 7Anand I , Chandranshekhan Y , De Giuli F , et al. Acute and chronic effects of propionyl-carnitine on the hemodynamics, exercise capacity , and hormones in patients with congestive heart failure[J]. Cardiovasc Drugs Ther, 1988,12:291-308.
  • 8IRAT A M, AKTAN F, OZANSOY G. Effects of L-carnitine treatment on oxidant/antioxidant state and vascular reactivity of streptozotocin-diabetic rat aorta[J]. J Pharm Pharmacol,2003, 55(10) :1389-1395.
  • 9GURLEK A, TUTAR E, AKCIL E, et al . The effects of Lcarnitine treatment on left ventricular function and erythrocyte superoxide dismutase activity in patients with ischemic cardiomyopathy[J]. Eur J Heart Fail, 2000, 2(2):189-193.
  • 10LOSTER H, BOHM U. L-carnitine reduces malondialdehyde concentrations in isolated rat hearts in dependence on perfusion conditions[J]. Mol Cell Biochem, 2001, 217(1-2):83-90.

共引文献2737

同被引文献12

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部